vWD

Prophylaxis in Patients with Von Willebrand Disease: Expert Perspectives and Shared Experiences
Prophylaxis in Patients with Von Willebrand Disease: Expert Perspectives and Shared Experiences
CME, CNE
Robert F. Sidonio, Jr., MD, Miguel A. Escobar, MD, Angela C. Weyand, MD
Release Date: September 27, 2022
Expiration Date: September 27, 2023

Von Willebrand Disease (VWD) is the most common inherited bleeding disorder in the United States. Despite this, however, many healthcare professionals lack the knowledge required to diagnose or treat VWD. This activity addresses the importance of long-term prophylaxis in VWD on guideline recommendations for long-term prophylaxis, and on emerging data regarding novel agents for prophylaxis in this disease. This program will conclude with case discussions designed to improve the awareness concerning symptoms of VWD and diagnostic assessments in order to better manage and treat the patients in your practice.

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Begin, Earn CreditView Only, No Credit
 

© 2022 MediCom Worldwide, Inc. All rights reserved